As of Dec 09
| +0.32 / +0.60%|
The 6 analysts offering 12-month price forecasts for Five Prime Therapeutics Inc have a median target of 57.50, with a high estimate of 65.00 and a low estimate of 54.00. The median estimate represents a +6.90% increase from the last price of 53.79.
The current consensus among 7 polled investment analysts is to Buy stock in Five Prime Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.